Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)

Trulieve Cannabis (NYSE:TRLV) reported third-quarter revenue of $230 million, up 4% from both a year earlier and the prior quarter on a medical-only basis, as growth in Georgia and Pennsylvania helped the cannabis operator exceed its guidance. The company generated net income of $1 million and adju

Management details Georgia growth and a new federal tax milestone.

Innovative Industrial Properties and Trulieve Cannabis may be turning things around.

Trulieve and Cronos are turning stronger results into market-beating gains.

Trulieve Cannabis (NYSE:TRLV) reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company’s June listing on the New York Stock Exchange. The company said reported second-quarter results inclu

Virginia and Texas could reshape the industry's next growth phase.

Trulieve is the more established cannabis multi-state operator, while Vireo Growth has been growing rapidly through acquisitions.

This vertically integrated cannabis operator reported significant insider selling in its latest SEC disclosure.

The listing matters, but fundamentals matter more.

A U.S.-based marijuana company is now trading on the New York Stock Exchange.

Investors seeking exposure to the marijuana market may now have a more attractive option to consider.

A major barrier for cannabis stocks just fell.